 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| Long-term Outcomes and Risk Factors for Reoperation After Surgical Treatment for Gastrointestinal Crohn Disease According to Anti-tumor Necrosis Factor-α Antibody Use: 35 Years of Experience at a Single Institute in Korea |
| Sang Mok Lee, Eon Chul Han, Seung-Bum Ryoo, Heung-Kwon Oh, Eun Kyung Choe, Sang Hui Moon, Joo Sung Kim, Hyun Chae Jung, Kyu Joo Park |
|
Ann Coloproctol. 2015;31(4):144-152. Published online August 31, 2015 DOI: https://doi.org/10.3393/ac.2015.31.4.144 |
|
Long-term Outcomes and Risk Factors for Reoperation After Surgical Treatment for Gastrointestinal Crohn Disease According to Anti-tumor Necrosis Factor-α Antibody Use: 35 Years of Experience at a Single Institute in Korea Annals of Coloproctology. 2015;31(4):144  Treatment Options after Anti-TNF Failure Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease. 2015;229-233 When and How to Stop Anti-TNF Treatment in Inflammatory Bowel Disease: Predictors of Relapse after Stopping Treatment Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease. 2015;224-228 Induced myelopathy after long-term anti-tumor necrosis factor alpha treatment Pediatric Rheumatology. 2011;9(S1): Risk of Serious Infection Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease. 2015;147-151 Neutralisation of Soluble Tumor Necrosis Factor Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease. 2015;83-89 Risk of Non-Hematologic Malignancy with Anti-TNF Therapy in Inflammatory Bowel Diseases Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease. 2015;138-142 Risk of Lymphoma Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease. 2015;143-146 Long-term clinical and real-world experience with Crohn’s disease treated with anti-tumor necrosis factor-α antibodies Intestinal Research. 2022;20(4):464-474 Preliminaries Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease. ; |
